Abbott Laboratories (NYSE:ABT) Upgraded to Buy from Hold
Abbott Laboratories (NYSE:ABT) received an upgrade by equity research analysts at Jefferies & Co Monday morning from Hold to Buy. Jefferies & Co also set a USD55.000 target price per…
Abbott Laboratories (NYSE:ABT) received an upgrade by equity research analysts at Jefferies & Co Monday morning from Hold to Buy. Jefferies & Co also set a USD55.000 target price per…